Geoffrey Michael Glass
EVP Global Strategy Sales Mark, Patheon.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Avadel Pharmaceuticals AVDL0 shares4Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Returned to company 75,904 shares at $21.00 of Avadel Pharmaceuticals4
- Feb 12, 2026Returned to company 69,075 shares at $21.00 of Avadel Pharmaceuticals4
- Feb 12, 2026Returned to company 22,005 shares at $21.00 of Avadel Pharmaceuticals4
- Jul 29, 2025Granted 11,000 shares of Avadel Pharmaceuticals5
- Dec 10, 2024Bought 10,204 shares at $9.80 of Avadel Pharmaceuticals6
- Dec 10, 2024Bought 10,075 shares at $9.89 of Avadel Pharmaceuticals6
- Jul 30, 2024Granted 11,000 shares of Avadel Pharmaceuticals7
- Aug 10, 2023Bought 14,000 shares at $13.40 of Avadel Pharmaceuticals8
- Jun 1, 2022Bought 45,000 shares at $2.14 of Avadel Pharmaceuticals9
- May 31, 2022Bought 45,000 shares at $2.14 of Avadel Pharmaceuticals10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvadel Pharmaceuticals, Board member
- 2SEC EDGARPatheon, President
- 3
- 4
- 5SEC EDGARForm 4 filed Jul 31, 2025
- 6SEC EDGARForm 4 filed Dec 10, 2024
- 7SEC EDGARForm 4 filed Aug 1, 2024
- 8SEC EDGARForm 4 filed Aug 11, 2023
- 9SEC EDGARForm 4 filed Jun 2, 2022
- 10SEC EDGARForm 4 filed Jun 3, 2022